Get the Stockscreener App
276.39
2.24%
-6.34
After Hours:
277.29
0.90
+0.33%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $276.39, with a volume of 2.13M.
It is down -2.24% in the last 24 hours and down -3.01% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$282.73
Open:
$281.04
24h Volume:
2.13M
Relative Volume:
0.96
Market Cap:
$148.80B
Revenue:
$34.76B
Net Income/Loss:
$6.62B
P/E Ratio:
22.60
EPS:
12.23
Net Cash Flow:
$10.61B
1W Performance:
-2.56%
1M Performance:
-3.01%
6M Performance:
-11.56%
1Y Performance:
-16.26%
1-Day Range:
$276.07
$282.94
1-Week Range:
$275.16
$282.94
52-Week Range:
$253.30
$339.17
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
276.39 | 149.94B | 34.76B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
755.39 | 676.48B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.06 | 423.36B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
218.34 | 373.87B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
124.12 | 244.98B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
82.81 | 209.89B | 63.43B | 16.42B | 14.72B | 6.49 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Mkt Perform |
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Voleon Capital Management LP Grows Position in Amgen Inc. $AMGN - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $1.45 Billion Stake in Amgen Inc. $AMGN - MarketBeat
Plato Investment Management Ltd Has $5.37 Million Stake in Amgen Inc. $AMGN - MarketBeat
Ransom Advisory Ltd Takes $580,000 Position in Amgen Inc. $AMGN - MarketBeat
Logan Capital Management Inc. Has $7.80 Million Position in Amgen Inc. $AMGN - MarketBeat
Fred Alger Management LLC Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
5,416 Shares in Amgen Inc. $AMGN Acquired by SCS Capital Management LLC - MarketBeat
Signature Estate & Investment Advisors LLC Acquires 1,872 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Zurich Insurance Group Ltd FI - MarketBeat
Empowered Funds LLC Cuts Position in Amgen Inc. $AMGN - MarketBeat
Amgen: Buy The Dip Opportunity (NASDAQ:AMGN) - Seeking Alpha
AG2R LA Mondiale Gestion D Actifs Makes New Investment in Amgen Inc. $AMGN - MarketBeat
2 Healthcare Dividend Stocks to Buy and Hold - The Motley Fool
Voya Investment Management LLC Acquires 133,777 Shares of Amgen Inc. $AMGN - MarketBeat
Guggenheim Maintains a Hold on Amgen Inc. (AMGN) - Yahoo Finance
Swedbank AB Has $209.80 Million Holdings in Amgen Inc. $AMGN - MarketBeat
1248 Management LLC Invests $318,000 in Amgen Inc. $AMGN - MarketBeat
Bontempo Ohly Capital Mgmt LLC Acquires 1,570 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by First Long Island Investors LLC - MarketBeat
Hodges Capital Management Inc. Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Caxton Associates LLP Buys New Stake in Amgen Inc. $AMGN - MarketBeat
Ascent Group LLC Has $4.66 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Coppell Advisory Solutions LLC Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Meiji Yasuda Life Insurance Co Cuts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Great Lakes Advisors LLC Sells 17,760 Shares of Amgen Inc. $AMGN - MarketBeat
CTC Alternative Strategies Ltd. Acquires New Holdings in Amgen Inc. $AMGN - MarketBeat
Ashton Thomas Private Wealth LLC Grows Stake in Amgen Inc. $AMGN - MarketBeat
Canada Post Corp Registered Pension Plan Invests $2.52 Million in Amgen Inc. $AMGN - MarketBeat
First Dallas Securities Inc. Cuts Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.81%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):